Sanofi Ends Research Into 2 Experimental Zika Vaccines After U.S. Funding Focus Shifts

Wall Street Journal: Sanofi Stops Work on Two Zika Vaccines “Drugmaker Sanofi SA has ended its development of two Zika virus vaccines, citing a decline in new infections and limits on U.S. government funding, in a move that illustrates the challenges in sustaining research in emerging infectious diseases after major outbreaks subside…” (Loftus, 9/6).

Read the original:
Sanofi Ends Research Into 2 Experimental Zika Vaccines After U.S. Funding Focus Shifts